New treatment possibility for some cancer patients

Larotrectinib is approved by NICE as an option for NTRK fusion-positive solid tumours Picture: iStock Essential facts Larotrectinib is one of a new breed of cancer drugs designed to target specific changes in the DNA of cancer cells, rather than where the disease is growing in the body. This means patients, including children, with various cancer types may benefit from its use. It is particularly useful for those patients at an advanced stage of cancer, when other options are limited or have been exhausted.

A new Texas law makes better treatment options possible for cancer patients

Opinion Cancer Drug Advancements Give New Hope to Metastatic Patients - The New York Times

New treatment possibility for some cancer patients

Patients With Liver Cancer Hold Their Breath for the Chance at a Better Treatment Outcome

Lynne Pearce, Page 12

i.guim.co.uk/img/media/58dccb84b5280f4698e629bef42

Scientists find possible genetic key to why some lymphoma patients don't respond to treatment

Changes in cancer treatment schedules may be possible, but proceed with caution

Four New Technologies That Will Change The Way Cancer Is Treated

How Immunotherapy Works To Treat Cancer

Study finds some prostate cancer patients can delay aggressive treatment

Common Questions About COVID-19 for Breast Cancer Patients

How Is Lung Cancer Diagnosed and Treated?

How structural racism can kill cancer patients - Nelson - 2020

Breakthrough Cancer Therapies Offer Hope for Patients

Many Cancers Are on the Rise in the U.S., Even as Overall Deaths Fall - WSJ